Cargando…
Automated High-Content Assay for Compounds Selectively Toxic to Trypanosoma cruzi in a Myoblastic Cell Line
BACKGROUND: Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, represents a very important public health problem in Latin America where it is endemic. Although mostly asymptomatic at its initial stage, after the disease becomes chronic, about a third of the infected patients progres...
Autores principales: | Alonso-Padilla, Julio, Cotillo, Ignacio, Presa, Jesús L., Cantizani, Juan, Peña, Imanol, Bardera, Ana I., Martín, Jose J., Rodriguez, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304841/ https://www.ncbi.nlm.nih.gov/pubmed/25615687 http://dx.doi.org/10.1371/journal.pntd.0003493 |
Ejemplares similares
-
High Throughput Screening for Anti–Trypanosoma cruzi Drug Discovery
por: Alonso-Padilla, Julio, et al.
Publicado: (2014) -
Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas’ disease drug discovery
por: MacLean, Lorna M., et al.
Publicado: (2018) -
Rate-of-Kill (RoK) assays to triage large compound sets for Chagas disease drug discovery: Application to GSK Chagas Box
por: Cantizani, Juan, et al.
Publicado: (2021) -
Development and Application of an Assay to Evaluate the Anti-Parasitic Effect of Humoral Responses against Trypanosoma cruzi
por: Martinez-Peinado, Nieves, et al.
Publicado: (2023) -
New Compound Sets Identified from High Throughput Phenotypic Screening Against Three Kinetoplastid Parasites: An Open Resource
por: Peña, Imanol, et al.
Publicado: (2015)